Skip to main content

Table 1 Demographics and clinical characteristics of HCV infected women enrolled in our study

From: HCV spread among female incarcerated population and treatment pathways to viral elimination in Italian prison settings: clinical perspectives and medico legal aspects

Variable Results (n = 24)
Italian nationality, n (%) 17 (70.8)
Age, mean ± SD 41 ± 9.5
PWIDs, n (%) 18 (75)
On OST, n (%) 13/18 (72.2)
Psychosis, n (%) 4 (16.6)
Alcohol abuse, n (%) 6 (25)
HBsAg, n (%) 1 (4.2)
HBcAb, n% 4 (16.6)
HIV, n (%) 6 (25)
Median (IQR) HCV RNA value 608,500 (339,575–1,449,312)
Genotypes, n (%) 1a 10 (41.6)
1b 1 (4.2)
2
3a 12 (50)
4 1 (4.2)
Fibrosis according to fibroscan® and FIB-4 value*, n (%) Low 15 (62.5)
Intermediate 6 (25)
Advanced 3 (12.5)
  1. IQR interquartile range, PWIDs people who inject drugs, OST opioid substitution therapy, ART anti-retroviral therapy. *Low = METAVIR F0-F1 or FIB-4 < 1.45; Intermediate = METAVIR F2-F3 or FIB-4 between 1.45 and 3.25; Advanced = METAVIR F4 or FIB-4 > 3.25